Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (20 ops.)
Latest filing published 14 May 2026 for Apellis Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySalePascal Deschatelets
Insider track record
Disclosed buys
0
Disclosed sells
20
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Pascal Deschatelets: trading record in brief
Pascal Deschatelets, listed as senior executive, appears in our data through filings on Apellis Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 24 May 2021 and 14 May 2026, the trades on record add up to 62 filings.
The open-market record consists of 20 sales worth €10.0M, with no purchase. Other entries cover 11 share grants and 29 option exercises. 2026 to date brings no purchases and 3 sales.
The newest entry dates from 14 May 2026: a transaction, in Apellis Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Pascal Deschatelets
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations62 total
1,177,222 sharesCommon StockSEC:0001193125-26-224609:0
25,840 shares0Common StockSEC:0001492422-26-000076:0
5,928 shares@ US$21.76540.9% of flowCommon StockSEC:0001492422-26-000058:0
909 shares@ US$19.79290.1% of flowCommon StockSEC:0001492422-26-000042:0
2,277 shares@ US$22.18720.4% of flowCommon StockSEC:0001492422-26-000029:0
12,780 shares@ US$3.760.4% of flowCommon StockSEC:0001127602-25-015285:0
826 shares@ US$29.52360.2% of flowCommon StockSEC:0001127602-25-002377:0
3,948 shares@ US$30.42551.0% of flowCommon StockSEC:0001127602-25-001833:0
750 shares@ US$29.95820.2% of flowCommon StockSEC:0001127602-25-001618:0
15,045 shares0Common StockSEC:0001127602-25-001618:1
2,288 shares@ US$28.70210.5% of flowCommon StockSEC:0001127602-25-001189:0
24,500 shares@ US$3.760.7% of flowCommon StockSEC:0001127602-24-016107:0
78,907 shares@ US$4.312.7% of flowCommon StockSEC:0001127602-24-014811:0
69,107 shares@ US$3.762.0% of flowCommon StockSEC:0001127602-24-012710:0
64,379 shares@ US$54.116526.9% of flowCommon StockSEC:0001127602-24-012710:1
4,728 shares@ US$54.91522.0% of flowCommon StockSEC:0001127602-24-012710:2
69,107 shares@ US$3.671.9% of flowCommon StockSEC:0001127602-24-009368:0
1,148 shares@ US$67.76690.6% of flowCommon StockSEC:0001127602-24-004716:0
874 shares@ US$64.13820.4% of flowCommon StockSEC:0001127602-24-002736:0
3,913 shares@ US$64.9962.0% of flowCommon StockSEC:0001127602-24-001937:0
6,743 shares0Common StockSEC:0001127602-24-001443:0
45,000 shares@ US$3.761.3% of flowCommon StockSEC:0001127602-23-027431:0
17,494 shares@ US$2.670.4% of flowCommon StockSEC:0001127602-23-027092:0
18,500 shares@ US$2.670.4% of flowCommon StockSEC:0001127602-23-025708:0
12,000 shares@ US$40.383.8% of flowCommon StockSEC:0001127602-23-025708:1
25 of 62 declarations
